Ms. Baird is the founder and CEO of Trove Analytics Inc. (TroveAx), a digital health predictive analytics company initially commercializing an early warning system based on only a single ECG lead input that gives doctors and nurses a heads up about impending hemodynamic instability hours in advance of other methods, enabling proactive actions to improve outcomes, avoid adverse events, shorten lengths of stay, and reduce costs. From 2010 to 2017, she served as the CEO of Accio Energy where she brought her track record of successfully commercializing transformational technologies to develop Accio’s revolutionary electrohydrodynamic wind energy systems. From 2005 to 2010, Ms. Baird was President and CEO of Accuri Cytometers, a rapidly growing company developing and marketing breakthrough life science products for research and clinical use. Ms. Baird co-founded Accuri and led the company from inception through development and commercialization. She raised over $30 million in venture equity and debt funding and achieved more than $10 million in sales, a global reach and near-profitability in just five years time. In 2011, Accuri was successfully sold to Becton Dickinson for $205 million, generating 5-6x returns for investors. Previously, Ms. Baird was a key member of the senior management team at Integrated Sensing Systems, Inc., a technology development firm focused on using micro-electromechanical systems for medical and scientific sensing applications. Earlier in her career, as a Vice President at Keane Consulting Group, she managed over $10 million in projects and helped the firm quintuple in size to over 150 staff.
Ms. Baird began her career in commercial banking. She received her MBA from the Kellogg Graduate School of Management, where she shared Top-of-Class honors, and a BA degree from the University of Michigan.